Supramolecular “Trojan Horse” for nuclear delivery of dual anticancer drugs Y Cai, H Shen, J Zhan, M Lin, L Dai, C Ren, Y Shi, J Liu, J Gao, Z Yang Journal of the American Chemical Society 139 (8), 2876-2879, 2017 | 267 | 2017 |
Broadly neutralizing synthetic cannabinoid vaccines M Lin, JC Lee, S Blake, B Ellis, LM Eubanks, KD Janda JACS Au 1 (1), 31-40, 2020 | 14 | 2020 |
Demystifying the Druggability of the MYC Family of Oncogenes NM Karadkhelkar, M Lin, LM Eubanks, KD Janda Journal of the American Chemical Society 145 (6), 3259-3269, 2023 | 10 | 2023 |
Polyphosphazene: a new adjuvant platform for cocaine vaccine development M Lin, A Marin, B Ellis, LM Eubanks, AK Andrianov, KD Janda Molecular Pharmaceutics 19 (9), 3358-3366, 2022 | 8 | 2022 |
Salicylanilide Analog Minimizes Relapse of Clostridioides difficile Infection in Mice S Blake, R Thanissery, AJ Rivera, MS Hixon, M Lin, CM Theriot, KD Janda Journal of Medicinal Chemistry 63 (13), 6898-6908, 2020 | 7 | 2020 |
Catalytic antibody blunts carfentanil-induced respiratory depression M Lin, LM Eubanks, NM Karadkhelkar, S Blake, KD Janda ACS Pharmacology & Translational Science 6 (5), 802-811, 2023 | 6 | 2023 |
Pharmacokinetic approach to combat the synthetic cannabinoid PB-22 M Lin, B Ellis, LM Eubanks, KD Janda ACS Chemical Neuroscience 12 (14), 2573-2579, 2021 | 6 | 2021 |
Vaccine design through transition state mimicry of heroin hydrolysis TF Belz, M Lin, LM Eubanks, B Ellis, KD Janda Tetrahedron Letters 71, 153045, 2021 | 1 | 2021 |
Evaluation of a hapten conjugate vaccine against the “zombie drug” xylazine M Lin, LM Eubanks, B Zhou, KD Janda Chemical Communications 60 (35), 4711-4714, 2024 | | 2024 |
Development of a vaccine against the synthetic opioid U-47700 H Park, M Lin, J Zhou, LM Eubanks, B Zhou, KD Janda Frontiers in Pharmacology 14, 1219985, 2023 | | 2023 |
Neutralizing and Catalytic Antibody Therapeutics Against Drugs of Abuse M Lin The Scripps Research Institute, 2023 | | 2023 |